Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. - Wikidata - awgldk - TriplyDB

Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

http://www.wikidata.org/entity/Q33389011

about

Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease Ultrasonography for diagnosis of cirrhosis in people with alcoholic liver disease Transient elastography for diagnosis of hepatic fibrosis in people with alcoholic liver disease Prediction of liver cirrhosis, using diagnostic imaging tools.The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance.Ultrasound in chronic liver disease.Liver elastography, comments on EFSUMB elastography guidelines 2013.Current status of novel antifibrotic therapies in patients with chronic liver disease CUFA algorithm: assessment of liver fibrosis using routine laboratory data.Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Thrombocytopenia in chronic liver disease.Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection Processes to manage analyses and publications in a phase III multicenter randomized clinical trial An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy Transient elastography for predicting esophageal/gastric varices in children with biliary atresia.A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years.Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial.Evaluation of Percutaneous Liver Biopsy Complications in Patients with Chronic Viral Hepatitis Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT.Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score.Task-based optimization of flip angle for fibrosis detection in T1-weighted MRI of liver Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients.Percutaneous liver biopsy practice patterns among Canadian hepatologists Treatment of a non-typical hepatic pseudolesion complicated by greatly elevated alpha fetoprotein: case report and literature review.Novel non-invasive biological predictive index for liver fibrosis in hepatitis C virus genotype 4 patients Radiofrequency ablation of high-grade dysplastic nodules.Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.The changing place of liver biopsy in clinical practice: an audit of an Australian tertiary hospital.Risk factors for bleeding after liver biopsy.Image-guided intervention in the coagulopathic patient.Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience.Hepatitis A to E: what's new?Safety and performance of liver biopsies in liver transplant recipients.Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.

P2860

Q24185989-5BDC900F-9C76-4AD9-862C-774255597729 Q24186412-1CE48862-EBFD-44A1-8F2B-AD2FFCB4B7A6 Q24187499-4E2F722A-F939-4FF0-8A82-0FAF10E77147 Q24202965-B503C197-BA7A-437F-847F-0AAE547F889E Q26795413-EE359669-7202-4E46-9A02-440CB6062453 Q28074484-378DCFF5-C338-4D59-BA3D-D6E99CEB017C Q28082686-8ED43936-1AD5-4DA2-A3A4-01D9F913DCC5 Q30355748-ECF4F274-D03E-4E33-B90F-6F51AE8AF403 Q30432218-0C43C5BA-3782-4875-9E6D-05793E7F3E1F Q30448132-0451B58F-96E1-42C1-A54C-D572714EDAF3 Q30473375-E9935E85-A2FF-4D42-9F17-C05E45235469 Q30834803-9C1A21DD-C0F8-49DD-AA54-AD20DA14FFFC Q33427048-EC69CDF0-423C-4ACA-AD68-2A1457E4F05D Q33436905-DB2039BE-1415-4584-9D25-A4A562E6D4D2 Q33440130-0B3BEF8A-CADB-4454-8D25-F5A5AD601B77 Q33694159-73565A35-CC8D-4606-AC22-4C86CE4C2B22 Q33742382-7E3AD262-F2DF-4AD4-8E2E-205453480EF4 Q33875847-824DADA7-B04D-440F-820A-A1C7980A7FE5 Q34103558-0DAC18FC-D4F6-4F13-8C4D-92314BA8F7D9 Q34502316-C192CFD4-AD1F-46BD-9002-3DBA889400AC Q35101419-D413681A-01A8-4259-8B95-43C3F1443682 Q35818743-98A85A2F-D542-42A8-9A15-61352EC313FF Q36319108-4E33BE6E-3119-47AE-8AA9-6CCEE7B162BE Q36484980-5141B2CB-648E-4E8C-9DD1-53C34600E618 Q36812170-BE80A65D-DBCC-48C6-B1B4-6AA4C3740AE1 Q36868728-642A9CDD-3CA1-4418-90C8-903F5FB3A6DF Q37112887-6A9BDC7D-E62D-4304-931B-E2C0BF0D115D Q37212257-88CEEC88-A96B-40EF-91AD-573436B2CFB7 Q37278359-25FD545D-D889-4D53-9BBE-E7446DEA5A89 Q37365505-BA4D7E3D-688B-4E1A-9648-BD3FA2A5664B Q37421485-8FF22B76-B2E5-4624-A214-83A4E2DE12ED Q37910079-C1C157BE-60E2-4E9C-81F6-C763357D69E2 Q37924180-70C6E5A5-5216-4DBE-9C14-35FEB65B2BB7 Q38235719-1574B5F0-73B8-404B-9F17-A20F0A4CAD6A Q38723525-D6D27CCA-DC51-4D2C-9270-1B76BB285B6E Q38750017-FA7B75A2-C84C-4223-B3A1-FF15D162F61B Q39027825-B7A768D2-36AB-4457-A9AA-0E6682787F6B Q39237214-FE4E49FC-5BC8-4C4C-9213-836CFFC742D1 Q40214428-2357E83D-895A-4701-B572-9BDF7C822ECE Q40513071-68F389EF-3519-477A-AE8C-47A8E5B5BE07

P2860

Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

http://www.wikidata.org/entity/Q33389011

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Complication rate of percutane ...... r disease in the HALT-C trial.

@ast

Complication rate of percutane ...... r disease in the HALT-C trial.

@en

type

label

Complication rate of percutane ...... r disease in the HALT-C trial.

@ast

Complication rate of percutane ...... r disease in the HALT-C trial.

@en

prefLabel

Complication rate of percutane ...... r disease in the HALT-C trial.

@ast

Complication rate of percutane ...... r disease in the HALT-C trial.

@en

P1433

Q33389011-5F4B791C-2321-4886-8122-B920C218394D

P1476

Q33389011-BB343E5B-3CF5-48BE-9B7E-8C54D57A5919

P2093

Q33389011-08023750-3E30-430F-B492-04D085DED719

Q33389011-09D5B86E-21AC-42F5-AF00-FB2AA62F6554

Q33389011-299E7F01-7668-4543-8C9B-69DDFC89463E

Q33389011-5B81351F-9CAE-477D-9FBE-954D6FF6D233

Q33389011-68381BCE-3F6E-46BB-A525-B51426448AE2

Q33389011-69B4284A-3A4B-42B3-97FD-E5E44E260E8E

Q33389011-8CFCAF11-2FA8-40B2-A5B3-C062B38CA181

Q33389011-A06514BB-F64A-423E-84BB-6E3DECA5A9E6

Q33389011-C11378E9-854F-4258-8668-7C8E3DCD8479

Q33389011-F8843139-77C7-45D9-BB16-2D8C741455C9

P2860

Q33389011-0075A7BC-9AA9-4F5A-BA48-C06534F72B69

Q33389011-09724A22-5EFB-4810-A644-C6E9CBA4B0DA

Q33389011-0D43E260-40D0-4CF5-80F2-8984BABF5EC5

Q33389011-1002E534-C491-4B1A-B152-B24240FFC39C

Q33389011-11173E48-8385-45D5-844F-8275F0052744

Q33389011-21D397D0-3ECF-4FC2-A6B5-010DBD7C9945

Q33389011-2812FE22-EE4F-4CCF-AE10-7E76CF2289C7

Q33389011-2B2AA3F4-E1AA-40DB-BC29-12F9533ED689

Q33389011-2D5EA1B0-FE4C-4FED-A507-32B14C2322B2

Q33389011-30ADB87C-5CCE-4566-88B2-6D7D62E298B7

P304

Q33389011-C7CE022D-B00F-44AE-8E6A-302549F20954

P31

Q33389011-5BC85FEC-9F75-4104-A3EC-C6D20C759A09

P356

Q33389011-64753EFC-4C08-419F-A245-89446182F2C0

P407

Q33389011-523C6C39-4F2F-4D16-974C-0822C3467366

P433

Q33389011-73580937-780B-4BF3-BD96-71287778052D

P478

Q33389011-85C22D9D-477E-4BB7-8761-662DD021CB51

P50

Q33389011-92AE34C7-C5B8-4230-AEC7-AA469715FD42

P577

Q33389011-FAC68D4E-2415-486D-97DE-6432A27C065C

P698

Q33389011-D3D3D4C0-465A-4FE7-83BA-7FE237310B0C

P921

Q33389011-A0C1B7DB-5EF1-4E3C-BC39-CE0E652C1DD9

P932

Q33389011-396571E3-B454-40F2-8437-1B405744AB11

P356

J.CGH.2010.03.025

P1433

Clinical Gastroenterology and Hepatology

P1476

Complication rate of percutane ...... r disease in the HALT-C trial.

@en

P2093

Gregory T Everson

http://www.w3.org/2001/XMLSchema#string

HALT–C Trial Group

http://www.w3.org/2001/XMLSchema#string

Herbert L Bonkovsky

http://www.w3.org/2001/XMLSchema#string

Jules L Dienstag

http://www.w3.org/2001/XMLSchema#string

Leonard B Seeff

http://www.w3.org/2001/XMLSchema#string

Marc G Ghany

http://www.w3.org/2001/XMLSchema#string

Mitchell L Shiffman

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

Teresa M Curto

http://www.w3.org/2001/XMLSchema#string

Timothy R Morgan

http://www.w3.org/2001/XMLSchema#string

P2860

Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London

Steatosis affects chronic hepatitis C progression in a genotype specific way

Histological grading and staging of chronic hepatitis

Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities.

Bleeding after liver biopsy.

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Outcome of patients hospitalized for complications after outpatient liver biopsy.

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

The role of liver biopsy in chronic hepatitis C.

Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review.

P304

877-883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2010.03.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Adrian M. Di Bisceglie

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20362695

http://www.w3.org/2001/XMLSchema#string

P921

P932

3771318

http://www.w3.org/2001/XMLSchema#string